Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 10/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | FBP1 | P09467 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30632931 | 0.81 | NFE2L2 (0.51) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL30632919 | 0.81 | GRM4 (0.47) | PTGS1 | |
| SCHEMBL30632891 | 0.80 | NPC1 (0.41) | CYP1A2HDAC1 | |
| SCHEMBL30632981 | 0.77 | RAB9A (0.43) | ERBB2CHRNA7HDAC1 | |
| SCHEMBL30632990 | 0.77 | KDM4E (0.47) | AHRPTGS1ERBB2CYP1A2 | |
| SCHEMBL28473621 | 0.77 | CYP1A1 (0.37) | — | |
| SCHEMBL2278845 | 0.77 | GRM4 (0.44) | CYP1A2 | |
| SCHEMBL2278846 | 0.77 | GRM4 (0.44) | CYP1A2 | |
| SCHEMBL13790273 | 0.75 | AHR (0.68) | AHRPTGS1NQO2CYP1A2HDAC1 | |
| SCHEMBL22931544 | 0.75 | AHR (0.68) | AHRPTGS1NQO2CYP1A2HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024200612-A1 | INHIBITORS OF URIDINE CATABOLISM AND/OR TRANSPORT FOR THERAPY | Université de Lausanne (CH) | 2024-10-03 | — | — | WO | claimed |
| CN-112920133-B | (E) -4-methyl-2- (4- (trifluoromethyl) styryl) oxazole compound and preparation method and application thereof | 中国医科大学 | 2022-09-16 | — | — | CN | claimed |
| CN-111886234-B | Heterocyclic mitochondrial activity inhibitors and uses thereof | 蒙特利尔大学 | 2023-12-15 | — | — | CN | disclosed |